HIV Treatment-Readiness Measure (HTRM) Validation

Validation of the HIV Treatment Readiness Measure (HTRM)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00686049

Enrollment

200

Registered

2008-05-29

Start date

2008-05-31

Completion date

2009-01-31

Last updated

2017-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV Treatment Readiness Measure (HTRM), Highly Active Antiretroviral Treatment (HAART), Adherence, Treatment readiness, HIV

Brief summary

The goal of this study is to assess the reliability of the HIV Treatment Readiness Measure (HTRM) to assist clinicians in: (1) determining whether or not youth living with HIV are ready to initiate HAART and (2) identifying youth who may be in need of additional support services to facilitate their adherence to HAART. The current study will examine the psychometric properties of the HTRM and establish its test-retest reliability over a two week period. If the HTRM is found to be reliable, a subsequent study will examine its predictive validity.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

13 Years to 24 Years

Healthy volunteers

Inclusion criteria

* HIV-positive youth, 13 years 0 days to 24 years 364 days of age * Either HAART naïve (defined as never having taken HAART) or HAART experienced (defined as having had at least one experience taking HAART and not having taken HAART for 30 days prior to study entry) * Not currently on HAART, but planning to initiate HAART within the next 2 months based on provider recommendation * Enrolled in care at an AMTU or a collaborating site * Able to speak and understand English * Willing to provide informed consent, or assent with parental permission (if required by the site IRB) for participation in this study.

Exclusion criteria

* Evidence of cognitive impairment or other mental condition that limits his/her ability to complete the assessment (per PI or designee discretion) * Determined by the PI (or designee) to be under the influence of psychoactive agents or intoxicated at the time of assessment to a degree that would interfere with successful completion of the questionnaire * Visibly distraught or unstable * Any clinical condition that would likely interfere with the participant's ability to complete the study Participants who are unable to speak English will be excluded from the initial testing of the HTRM's reliability and validity in keeping with traditional tool development strategies. If the initial study indicates that the English version of the HTRM is reliable and valid, appropriate methods will be employed to translate the instrument into Spanish and the reliability and validity will be re-examined for the Spanish version.

Design outcomes

Primary

Measure	Time frame
To examine the factor structure and estimate the internal consistency of each factor of the HTRM.	1 year
To estimate the test-retest reliability of the HTRM.	Entry, Week 2

Secondary

Measure	Time frame
To determine an appropriate system for scoring the HTRM.	1 year
To examine the acceptability of the HTRM.	Entry, Week 2

Countries

Puerto Rico, United States

Outcome results